课题基金 / 基金详情

Development of New Immunotherapy for Oral Cancer Using Dendritic Cells

Development of New Immunotherapy for Oral Cancer Using Dendritic Cells
利用树突状细胞开发新的口腔癌免疫疗法
批准号:
13470443
负责人:
MATSUMOTO Goichi
金额:
$6.08万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002

项目摘要

项目成果

MATSUMOTO Goichi的其他基金

相似基金

相关文献

中文摘要
翻译
自然杀伤T(NKT)细胞在被合成的CD 1d配体α-半乳糖神经酰胺(α-GalCer)通过其不变的Vα14受体刺激后产生大量与Th 1应答(IFN-γ)和Th 2应答(IL-4)相关的细胞因子。然而,粘附或共刺激分子在α-GalCer激活NKT细胞中所起的作用仍不清楚。为了解决这一问题,使用LFA-1^+和CD 28 ^+小鼠研究α-GalCer刺激后NKT细胞产生IL-4和IFN-γ的情况。LFA-1^+小鼠表现出对体外和体内极化Th 2型应答的IL-4产生增加,表现为B细胞活化和血清IgE升高。相反,在CD 28 ^+小鼠中,IL-4和IFN-γ的产生受损,导致Th 2型应答严重丧失,表现为血清IgE消失。这些结果表明,LFA-1粘附受体和CD 28共刺激受体选择性地调节α-GalCer激活的NKT细胞的Th 1和Th 2样功能。
英文摘要
Natural killer T (NKT) cells produce large amounts of cytokines associated with both the Th1 response (IFN-γ) and Th2 response (IL-4) after being stimulated by the synthetic CD1d ligand α-galactosylceramide (α-GalCer) by their invariant Vα14 receptor. However, the role played by adhesion or co-stimulation molecules in the activation of NKT cells by α-GalCer remains unclear. To address this issue, LFA-1^+ and CD28^+ mice were used to investigate IL-4 and IFN-γ production by NKT cells following α-GalCer stimulation. LFA-1^+ mice showed increased IL-4 production in response to in vitro and in vivo polarized Th2-type responses, represented by activation of B cells and serum IgE elevation. In contrast, impairment of production of IL-4 and IFN-γ in CD28^+ mice resulted in a profound inability to polarize the Th2-type response, represented by the abolishment of serum IgE. These results imply that the LFA-1 adhesion receptor and the CD28 co-stimulatory receptor selectively regulate Th1- and Th2-like functions of α-GalCer-activated NKT cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Elucidation of lymph node metastasis inhibition mechanism of oral cancer targeting sphingomyelin synthetase
  • 批准号:
    16K11710
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.0万
  • 财政年份:
    2016
  • 负责人:
    MATSUMOTO Goichi
  • 依托单位:
Establishment of inhibition of Oral cancer lymph node metastasis by suppressing lymphangiogenesis by transcription factor CSDA
  • 批准号:
    21592541
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.91万
  • 财政年份:
    2009
  • 负责人:
    MATSUMOTO Goichi
  • 依托单位:
Study of gene therapy with VEGF RNA interference against oral cancer
  • 批准号:
    16390599
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $6.59万
  • 财政年份:
    2004
  • 负责人:
    MATSUMOTO Goichi
  • 依托单位:
A study of angiostatin gene therapy for squamous cell carcinoma in vivo
  • 批准号:
    11672023
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.5万
  • 财政年份:
    1999
  • 负责人:
    MATSUMOTO Goichi
  • 依托单位:
国内基金
海外基金
炎症因子水平变化与NKT细胞功能障碍在苯中毒免疫损伤中的作用机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    李小兵
  • 依托单位:
ICAM1与NKT-亚群在苯中毒免疫损伤中的调控作用及机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    李小兵
  • 依托单位:
肠道嗜黏蛋白阿克曼菌调控肝脏NKT细胞功能抑制良性心理应激小鼠结直肠癌肝转移的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    范兴丽
  • 依托单位:
以 NKT 细胞激动剂为内嵌佐剂的槟榔碱疫苗 的设计合成与免疫评价
  • 批准号:
    TGY24B020006
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    殷旭光
  • 依托单位: